Video

A New Decade Of Outsourcing: What Can We Expect?

Source: Outsourced Pharma

Will the "Twenty-Twenties" be as exciting as they sound for our industry? For certain, nobody saw a coronavirus outbreak put outsourcing in such a public light.

Outsourced Pharma hosted a live, virtual discussion in June 2020 focusing on four key areas: continuous manufacturing; cell and gene therapy influences; new sponsor-CDMO service models; and "Supply Chain 4.0."

Our esteemed panel included Darren Dasburg, (former) VP & Head Learning and Development Global Operations | AstraZeneca, Shawn Eisenberg, Executive Director, Manufacturing & Supply Chain | ImmunoGen, Praveen Prasanna, Sr. Director, Technical Operations | AVEO Oncology, Jana Spes, Head of Pharmaceutical Development & Manufacturing Sciences | Ironwood Pharmaceuticals, and Mark Butchko, Sr. Director, Quality Assurance - Development | Lilly and Company.

VIEW THE VIDEO!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: